Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial.

Babak GolkhalkhaliRetnagowri RajandramAudra Shaleena PalianyGwo Fuang HoWan Zamaniah Wan IshakChe Shafini JohariKin Fah Chin

Published in: Asia-Pacific journal of clinical oncology (2017)

The combined supplementation with MCP and omega-3 fatty acid may improve quality of life, reduce certain inflammatory biomarkers and relieve certain side effects of chemotherapy in colorectal patients on chemotherapy.

Keyphrases

end stage renal disease
fatty acid
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
microbial community
single cell
oxidative stress
locally advanced
high resolution
radiation therapy
patient reported outcomes
rectal cancer